This federal contract award, valued at $2,210.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Albuterol HFA 90 MCG Inhaler 18GM, a critical medication used for the treatment of respiratory conditions. The contract has an ultimate completion date of December 18, 2024 and is a firm fixed-price delivery order. This contract award is not associated with a set-aside program, indicating open competition. AmerisourceBergen, as the prime contractor, is responsible for supplying this medication to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions served by the DLA. The company maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the U.S. military and federal healthcare programs globally.
Generated 3/18/25, 9:49 AM